What Recent Market Trends Mean for TG Therapeutics Inc’s (TGTX) Stock
In the past week, TGTX stock has gone up by 0.72%, with a monthly gain of 15.57% and a quarterly plunge of -9.18%. The volatility
In the past week, TGTX stock has gone up by 0.72%, with a monthly gain of 15.57% and a quarterly plunge of -9.18%. The volatility
TG Therapeutics Inc (NASDAQ: TGTX) has a price-to-earnings ratio of 1067.38x that is above its average ratio. Additionally, the 36-month beta value for TGTX is
TG Therapeutics Inc (NASDAQ: TGTX)’s stock price has dropped by -2.44 in relation to previous closing price of 16.78. Nevertheless, the company has seen a
The stock of TG Therapeutics Inc (NASDAQ: TGTX) has decreased by -0.50 when compared to last closing price of 17.96. Despite this, the company has
TG Therapeutics Inc (NASDAQ: TGTX) has seen a rise in its stock price by 0.30 in relation to its previous close of 13.32. However, the
In the past week, TGTX stock has gone down by -12.85%, with a monthly decline of -12.21% and a quarterly surge of 17.50%. The volatility
Moreover, the 36-month beta value for TGTX is 2.31. The public float for TGTX is 136.40M and currently, short sellers hold a 21.35% of that
The 36-month beta value for TGTX is also noteworthy at 2.34. The public float for TGTX is 136.40M, and at present, short sellers hold a
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.